Alyftrek 10-50-125 MG tablet 14S
Ended Awarded
- Contract number
- SPE2DB25FZP80
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $20,993
Award facts
- Contract value 100% obligated
- $20,993.31 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $20,993.31 by the Defense Logistics Agency (DLA) on June 3, 2025, with an ultimate completion date of June 4, 2025. The contract is for the supply of ALYFTREK 10-50-125 mg tablets in quantities of 14 units and was awarded without a set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract with the DLA valued at $499,999,999 and valid through November 2026, which enables the agency to procure a comprehensive range of pharmaceutical products supporting military health facilities nationwide.
As a critical supplier in the federal pharmaceutical supply chain, DMS Pharmaceutical Group leverages its IDC vehicle with the DLA's SPE2DB program to deliver prescription medications, biologics, over-the-counter medications, and medical consumables directly to Department of Defense healthcare sites. The company has established a robust portfolio of federal contract awards covering diverse pharmaceutical products ranging from specialty medications to vaccines and injections. This delivery order represents the company's continued role in providing essential pharmaceutical supplies to support military medical operations and healthcare requirements across the department.
Quick answers
Who was awarded contract SPE2DB25FZP80?
SPE2DB25FZP80 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on June 3, 2025.
How much is contract SPE2DB25FZP80 worth?
The government has obligated $20,993 on SPE2DB25FZP80.
Is contract SPE2DB25FZP80 an order under another contract?
Yes. SPE2DB25FZP80 is a delivery order under SPE2DB22D9102, an indefinite delivery contract.
Was contract SPE2DB25FZP80 competed?
The extent of competition for SPE2DB25FZP80 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award